Moderlax (Bisacodyl)

Bisacodyl, the active ingredient in Moderlax, is a stimulant laxative presented as an oral tablet for oral use. It treats constipation and is employed for bowel preparation before diagnostic procedures in adult patients.

GNH USA supplies Moderlax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Bisacodyl acts on the lower gastrointestinal tract to relieve functional constipation and to prepare the bowel for diagnostic examinations.

- Constipation: provides stimulant action that promotes bowel movements in patients with functional constipation. - Bowel preparation before diagnostic procedures: clears the colon to improve visualization during colonoscopy or radiologic studies. - Fecal impaction: helps evacuate hardened stool in cases of impaction.

Bisacodyl may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal cramps or pain - Diarrhea or loose stools - Nausea - Rectal irritation or burning - Urgency to defecate - Flatulence

Serious or Rare Side Effects: - Severe electrolyte imbalance or dehydration - Allergic reactions such as rash, angioedema, or anaphylaxis - Colonic perforation (very rare) - Melanosis coli with prolonged use

When using Bisacodyl, consider the following safety measures.

- Do not exceed the recommended dose: follow prescriber instructions to avoid excessive laxation. - Avoid use in patients with intestinal obstruction: the drug may worsen blockage. - Caution in inflammatory bowel disease: stimulant action can exacerbate symptoms. - Use with care in the elderly: increased risk of dehydration and electrolyte loss. - Pregnancy and breastfeeding: safety not established; consult a healthcare professional. - Store at ambient temperature: keep in the original pack, protect from moisture.

Bisacodyl can interact with other medicines, requiring attention to dosage and monitoring.

Major Interactions (Avoid): - Concurrent use with other stimulant laxatives: may cause severe diarrhea and electrolyte disturbances. - Co‑administration with anticholinergic agents: may reduce the laxative effect. - Use with high‑dose mineral oil: may impair absorption of the laxative.

Moderate Interactions (Monitor Closely): - Diuretics: monitor electrolytes, especially potassium. - Cardiac glycosides: watch for potassium depletion that can affect drug levels. - Magnesium‑containing antacids: may increase the laxative effect and cause loose stools.